Response to Comment on "A commensal strain of <i>Staphylococcus epidermidis</i> protects against skin neoplasia" by Nakatsuji <i>et al</i>.

Abstract

Kozmin <i>et al.</i> contend that observations previously reported regarding the antimicrobial and antitumor activities of 6-<i>N</i>-hydroxy aminopurine (6-HAP) were incorrect. Their conclusions rely on poorly characterized reagents and focus strictly on in vitro techniques without validation in relevant mammalian model systems. We are pleased to be able to illuminate the weaknesses in their technical comment. The totality of current results continues to support our original conclusion that a strain of the common human commensal skin bacterium, <i>Staphylococcus epidermidis</i>, produces 6-HAP that can inhibit tumor growth.